View Author
patient children group height level study gh treatment treatment growth syndrome hormone effect therapy prader-willi syndrome ox /pl therapy endocrinol mutation igf-i signi ficantly adult result metab value development baseline signi turner syndrome netherland turner control table analysis prader-willi body composition change dosage voice ox /pl adult height month reference androgen infant increase dutch deficiency growth hormone treatment score difference prader –willi syndrome growth hormone ficantly metyrapone test scoliosi puberty endocrinology metyrapone serum randomized control group apnea center composition gh therapy estrogen range journal height sds hospital dosage groups 0.03 prepubertal cortisol apnea index glucose 0.06 library erasmus mc family /liter prader
10 Most Recent Publications
|
Ovarian function and reproductive hormone levels in girls with prader-willi syndrome: A longitudinal study
(Article)
Siemensma, E.P.C. Alfen- van der Velden, A.A.E.M. van Otten, B.J. Laven, J.S.E. Hokken-Koelega, A.C.S. |
2012-09-01
|
|
Pubarche and serum dehydroepiandrosterone sulphate levels in children with Prader-Willi syndrome
(Article)
Siemensma, E.P.C. Lind van Wijngaarden, R.F.A. de Jong, F.H. de Otten, B.J. Hokken-Koelega, A.C.S. |
2011-07-01
|
|
Effect of oxandrolone on glucose metabolism in growth hormone-treated girls with turner syndrome
(Article)
Menke, L.A. Sas, T.C.J. Stijnen, Th. Zandwijken, G.R.J. Muinck Keizer-Schrama, S.M.P.F. de Otten, B.J. Wit, J.M. |
2011-02-01
|
|
The Effect of Oxandrolone on Voice Frequency in Growth Hormone-Treated Girls With Turner Syndrome
(Article)
Menke, L.A. Sas, T.C.J. Koningsbrugge, S.H.L. van Ridder, M.A.J. de Zandwijken, G.R.J. Boersma, B. Dejonckere, P.H. Muinck Keizer-Schrama, S.M.P.F. de Otten, B.J. Wit, J.M. |
2010-10-25
|
|
Adult height in children with growth hormone deficiency: A randomized, controlled, growth hormone dose-response trial
(Article)
Sas, T.C.J. Ridder, M.A.J. de Wit, J.M. Rotteveel, J. Oostdijk, W. Reeser, H.M. Otten, B.J. Muinck Keizer-Schrama, S.M.P.F. de |
2010-08-01
|
|
The effect of oxandrolone on body proportions and body composition in growth hormone-treated girls with Turner syndrome
(Article)
Menke, L.A. Sas, T.C.J. Zandwijken, G.R.J. Ridder, M.A.J. de Stijnen, Th. Muinck Keizer-Schrama, S.M.P.F. de Otten, B.J. Wit, J.M. |
2010-08-01
|
|
Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome
(Article)
Menke, L.A. Sas, T.C.J. Westerlaken, C. Reeser, H.M. Trotsenburg, A.S.P. van Gevers, E.F. Buuren, S. van Dejonckere, P.H. Hokken-Koelega, A.C.S. Otten, B.J. Wit, J.M. Muinck Keizer-Schrama, S.M.P.F. de Zandwijken, G.R.J. Ridder, M.A.J. de Odink, R.J.H. Jansen, M. Delemarre-van Waal, H.A. de Stokvis-Brantsma, W.H. Waelkens, J.J. |
2010-03-01
|
|
The effect of the weak androgen oxandrolone on psychological and behavioral characteristics in growth hormone-treated girls with Turner syndrome
(Article)
Menke, L.A. Sas, T.C.J. Visser, M. Kreukels, B.P.C. Stijnen, Th. Zandwijken, G.R.J. Muinck Keizer-Schrama, S.M.P.F. de Otten, B.J. Wit, J.M. Cohen-Kettenis, P.T. |
2010-03-01
|
|
Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome
(Article)
Lind van Wijngaarden, R.F.A. de Siemensma, E.P.C. Bocca, G. Houdijk, E.C.A.M. Hoorweg-Nijman, J.J.G. Vreuls, R.C.F.M. Jira, P.E. Trotsenburg, A.S.P. van Bakker, B. Schroor, E.J. Pilon, J.W. Wit, J.M. Festen, D.A.M. Drop, S.L.S. Hokken-Koelega, A.C.S. Otten, B.J. Mil, E.G.A.H. van Rotteveel, J. Odink, R.J.H. Bindels-de Heus, G.C.B. Leeuwen, M. van Haring, D.A.J.P. |
2009-11-01
|
|
Bone mineral density and effects of growth hormone treatment in prepubertal children with Prader-Willi syndrome: A randomized controlled trial
(Article)
Lind van Wijngaarden, R.F.A. de Festen, D.A.M. Hokken-Koelega, A.C.S. Otten, B.J. Mil, E.G.A.H. van Rotteveel, J. Odink, R.J.H. Leeuwen, M. van Haring, D.A.J.P. Bocca, G. Houdijk, E.C.A.M. |
2009-10-19
|